| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8334404b2ff5735f51319ce4eed04a28 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-592
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-782 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-6615
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-365 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 |
| filingDate |
2012-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e53ba20531b8dd551e97bcfa3f95a1e |
| publicationDate |
2014-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014377200-A1 |
| titleOfInvention |
Methods and compositions for alteration of skin pigmentation |
| abstract |
Compositions are provided that possess levels of phytic acid and optionally a hydroxy acid and/or azelaic acid that act synergistically with the phytic acid to reduce melanin levels in skin. Improved reduction in melanin levels and hyperpigmentation are achieved at low levels of azelaic acid and phytic acid such that greater comfort and reduced irritation are observed at an administration site. Processes of reducing melanin levels or treating hyperpigmentation are provided by topically administering compositions of the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021386646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017303861-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10820863-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11779532-B2 |
| priorityDate |
2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |